Sally Beauty Holdings (SBH) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Jan, 2026Executive summary
Net sales declined 2.8% year-over-year to $883 million, impacted by macroeconomic headwinds and 110 basis points of unfavorable foreign currency, while comparable sales fell 1.3%.
Adjusted operating earnings grew 10%, operating earnings increased 16.4% to $69.4 million, and adjusted EPS rose 20% to $0.42, with GAAP diluted EPS at $0.38.
Operating margin expanded 130 basis points to 7.9% (GAAP) and 90 basis points to 8.5% (adjusted), marking the third consecutive quarter of margin expansion.
Cash flow from operations was $51 million, with $32 million in free cash flow, and strong liquidity maintained at $574.9 million.
Strategic initiatives in digital marketplaces, product innovation, and customer-centric services drove comp sales growth, offsetting some external pressures.
Financial highlights
Consolidated net sales were $883 million, down 2.8% year-over-year, with a 1.3% decline in comparable sales and 110 basis points of unfavorable FX impact.
Gross margin expanded 100 basis points to 52%, driven by lower distribution/freight costs and reduced shrink.
Adjusted EBITDA increased 5.3% to $104.8 million, with margin up 90 basis points to 11.9%.
Free cash flow for the quarter was $32 million, with $90 million delivered year-to-date and a full-year target of $180–$200 million.
Interest expense decreased 20.6% for the quarter due to lower debt balances and rates.
Outlook and guidance
Fiscal 2025 comparable sales expected to be flat to down 1%, revised from prior flat to up 2%.
Consolidated net sales projected to be about 75 basis points lower than comps due to FX; adjusted operating margin guidance lowered to 8–8.5%.
Q3 guidance: comparable sales flat to down 2%, net sales 50 basis points below comps, and $20 million each in share repurchases and debt repayment.
Management anticipates sufficient liquidity from cash, operations, and available credit to fund working capital and capital expenditures over the next twelve months.
Latest events from Sally Beauty Holdings
- Adjusted EPS up 12% on 0.6% sales growth; guidance raised as cash flow supports buybacks.SBH
Q1 20269 Feb 2026 - Q4 and FY24 saw sales and margin growth, fueling a positive 2025 outlook and capital returns.SBH
Q4 20243 Feb 2026 - Q3 sales up 1.2%, but net earnings fell 25.8% amid margin and interest pressures.SBH
Q3 20242 Feb 2026 - Operating margin and EPS rose as guidance was raised, despite lower sales and macro uncertainty.SBH
Q3 202523 Jan 2026 - Net sales and margins grew, net earnings surged, and guidance remains positive despite FX headwinds.SBH
Q1 202523 Jan 2026 - FY2025 saw strong sales, margin gains, and cash flow, supporting double-digit EPS growth outlook.SBH
Q4 202523 Jan 2026 - Virtual annual meeting to vote on directors, compensation, and auditor, with online access promoted.SBH
Proxy Filing10 Dec 2025 - Strong FY25 results, digital expansion, and robust ESG focus drive governance and compensation.SBH
Proxy Filing10 Dec 2025 - Board recommends all management proposals, emphasizing growth, innovation, and ESG leadership.SBH
Proxy Filing2 Dec 2025